First-in-human global multi-center study of RLY-2608, a pan mutant and isoform selective PI3Ka inhibitor, as a single agent in advanced solid tumor patients and in combination with fulvestrant in patients with advanced breast cancer
Fulvestrant;RLY-2608
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: First-in-human global multi-center study of RLY-2608, a pan mutant and isoform selective PI3Ka inhibitor, as a single agent in advanced solid tumor patients and in combination with fulvestrant in patients with advanced breast cancer ### Output: Fulvestrant;RLY-2608